References

1. Goldhaber SZ, Visani L, De Rosa M. Acute pulmonary embolism: clinical outcomes in the International Cooperative Pulmonary Embolism Registry (ICOPER). Lancet. 1999 Apr 24; 353(9162): 1386-9. PubMed | Google Scholar


2. Kasper W, Konstantinides S, Geibel A et al. Management strategies and determinants of outcome in acute major pulmonary embolism: results of a multicenter registry. J Am Coll Cardiol. 1997 Nov 1; 30(5): 1165-71. PubMed | Google Scholar


3. Buller HR, Prins MH, Lensin AW et al. Oral rivaroxaban for the treatment of symptomatic pulmonary embolism. N Engl J Med. 2012 Apr 5; 366(14): 1287-97. PubMed | Google Scholar


4. Planquette B, Belmont L, Guy Meyer, Olivier Sanchez. Prise en charge diagnostique et thérapeutique de l'embolie pulmonaire grave. Rev Mal Respir. 2011 Jun; 28(6): 778-89. PubMed | Google Scholar


5. Meyer G, Sanchez O, Planquette B. Embolie pulmonaire de gravité intermédiaire: thrombolyse ou non? Réanimation. Mars 2015; 24(2): pp 98-103. Google Scholar


6. Meyer G, Vicaut E, Danays T, Agnelli G et al . Fibrinolysis for patients with intermediate-risk pulmonary embolism. N Engl J Med. 2014 Apr 10; 370(15): 1402-11. PubMed | Google Scholar


7. Kucher N, Boekstegers P, Muller OJ, Kupatt C, Beyer-Westendorf J, Heitzer T et al. Randomized controlled trial of ultrasound-assisted catheter-directed thrombolysis for acute intermediate-risk pulmonary embolism. Circulation. 2014 Jan 28; 129(4): 479-86. PubMed | Google Scholar